The role of microRNAs in human liver cancers

Seminars in Oncology

Volumn 38, Issue 6, 2011, Pages 752-763

  Braconi, Chiara ^a   Henry, Jon C ^a   Kogure, Takayuki ^b   Schmittgen, Thomas ^a   Patel, Tushar ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 155; MICRORNA 199A; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 26; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER MODEL; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE TARGETING; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION;

CARCINOMA, HEPATOCELLULAR; EPIGENESIS, GENETIC; HEPATITIS B, CHRONIC; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MICRORNAS; PROGNOSIS;

EID: 81155138127     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.08.001     Document Type: Article

References (87)

1. B.K. Edwards, E. Ward, and B.A. Kohler Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates Cancer 116 2010 544 573
2. B.R. Cullen Transcription and processing of human microRNA precursors Mol Cell 16 2004 861 865
3. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
4. Y. Murakami, T. Yasuda, and K. Saigo Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues Oncogene 25 2006 2537 2545
5. A. Budhu, H.L. Jia, and M. Forgues Identification of metastasis-related microRNAs in hepatocellular carcinoma Hepatology 47 2008 897 907
6. J. Yao, L. Liang, and S. Huang MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma Hepatology 51 2010 846 856
7. J. Jiang, Y. Gusev, and I. Aderca Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival Clin Cancer Res 14 2008 419 427
8. J. Ji, J. Shi, and A. Budhu MicroRNA expression, survival, and response to interferon in liver cancer N Engl J Med 361 2009 1437 1447
9. G.A. Calin, C. Sevignani, and C.D. Dumitru Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc Natl Acad Sci U S A 101 2004 2999 3004
10. G.A. Calin, C.D. Dumitru, and M. Shimizu Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 99 2002 15524 15529
11. J. Ding, S. Huang, and S. Wu Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA Nat Cell Biol 12 2010 390 399
12. G.A. Calin, M. Ferracin, and A. Cimmino A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia N Engl J Med 353 2005 1793 1801
13. J. Yang, F. Zhou, and T. Xu Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas Mutat Res 638 2008 205 209
14. P. Fasanaro, S. Greco, M. Ivan, M.C. Capogrossi, and F. Martelli microRNA: emerging therapeutic targets in acute ischemic diseases Pharmacol Ther 125 2010 92 104
15. P. Qi, T.H. Dou, F.G. Zhou, X. Gu, H. Wang, and C.F. Gao Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection Hum Immunol 71 2010 621 626
16. Y. Saito, G. Liang, and G. Egger Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells Cancer Cell 9 2006 435 443
17. F. Meng, H. Wehbe-Janek, R. Henson, H. Smith, and T. Patel Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes Oncogene 27 2008 378 386
18. J. Datta, H. Kutay, and M.W. Nasser Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis Cancer Res 68 2008 5049 5058
19. F.Y. Meng, C. Braconi, E. Swenson, L. Khrapenko, and T. Patel Epigenetic activation of miR-34a contributes to an invasive phenotype in hepatocellular cancer Hepatology 48 2008 387A 388A
20. M.A. Feitelson, and J. Lee Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis Cancer Lett 252 2007 157 170
21. M. Raidl, C. Pirker, and R. Schulte-Hermann Multiple chromosomal abnormalities in human liver (pre)neoplasia J Hepatol 40 2004 660 668
22. P.E. Zondervan, J. Wink, and J.C. Alers Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias J Pathol 192 2000 207 215
23. W.B. Jin, F.L. Wu, D. Kong, and A.G. Guo HBV-encoded microRNA candidate and its target Comput Biol Chem 31 2007 124 126
24. X. Zhang, S. Liu, T. Hu, S. Liu, Y. He, and S. Sun Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression Hepatology 50 2009 490 499
25. S. Ura, M. Honda, and T. Yamashita Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma Hepatology 49 2009 1098 1112
26. X. Liu, T. Wang, T. Wakita, and W. Yang Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells Virology 398 2010 57 67
27. G. Randall, A. Grakoui, and C.M. Rice Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs Proc Natl Acad Sci U S A 100 2003 235 240
28. C. Braconi, N. Valeri, and P. Gasparini Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes Clin Cancer Res 16 2010 957 966
29. M. Sidorkiewicz, M. Grek, B. Jozwiak, E. Majda-Stanislawska, A. Piekarska, and J. Bartkowiak Expression of microRNA-155 precursor in peripheral blood mononuclear cells from hepatitis Cpatients after antiviral treatment Acta Virol 54 2010 75 78
30. S.C. le, R. Nagel, and D.A. Egan Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation EMBO J 26 2007 3699 3708
31. P. Pineau, S. Volinia, and K. McJunkin miR-221 overexpression contributes to liver tumorigenesis Proc Natl Acad Sci U S A 107 2010 264 269
32. A. Koff How to decrease p27Kip1 levels during tumor development Cancer Cell 9 2006 75 76
33. R. Visone, L. Russo, and P. Pallante MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle Endocr Relat Cancer 14 2007 791 798
34. F. Fornari, L. Gramantieri, and M. Ferracin MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma Oncogene 27 2008 5651 5661
35. L. Gramantieri, F. Fornari, and M. Ferracin MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality Clin Cancer Res 15 2009 5073 5081
36. Q.W. Wong, A.K. Ching, and A.W. Chan MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling Clin Cancer Res 16 2010 867 875
37. M. Garofalo, L.G. Di, and G. Romano miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation Cancer Cell 16 2009 498 509
38. T. Ueki, J. Fujimoto, T. Suzuki, H. Yamamoto, and E. Okamoto Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma Hepatology 25 1997 862 866
39. H. Kutay, S. Bai, and J. Datta Downregulation of miR-122 in the rodent and human hepatocellular carcinomas J Cell Biochem 99 2006 671 678
40. L. Gramantieri, M. Ferracin, and F. Fornari Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma Cancer Res 67 2007 6092 6099
41. J. Chang, E. Nicolas, and D. Marks miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1 RNA Biol 1 2004 106 113
42. S. Bai, M.W. Nasser, and B. Wang MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib J Biol Chem 284 2009 32015 32027
43. C. Coulouarn, V.M. Factor, J.B. Andersen, M.E. Durkin, and S.S. Thorgeirsson Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties Oncogene 28 2009 3526 3536
44. J.I. Henke, D. Goergen, and J. Zheng microRNA-122 stimulates translation of hepatitis C virus RNA EMBO J 27 2008 3300 3310
45. C.L. Jopling, K.L. Norman, and P. Sarnow Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122 Cold Spring Harb Symp Quant Biol 71 2006 369 376
46. R. Zhang, L. Wang, G.R. Yu, X. Zhang, L.B. Yao, and A.G. Yang MicroRNA-122 might be a double-edged sword in hepatocellular carcinoma Hepatology 50 2009 1322 1323
47. I.M. Pedersen, G. Cheng, and S. Wieland Interferon modulation of cellular microRNAs as an antiviral mechanism Nature 449 2007 919 922
48. J. Kota, R.R. Chivukula, and K.A. O'Donnell Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model Cell 137 2009 1005 1017
49. W.E. Naugler, T. Sakurai, and S. Kim Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 317 2007 121 124
50. J.M. Llovet, S. Ricci, and V. Mazzaferro Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
51. F. Meng, R. Henson, H. Wehbe-Janek, K. Ghoshal, S.T. Jacob, and T. Patel MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology 133 2007 647 658
52. H. Zhang, I. Ozaki, and T. Mizuta Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma Oncogene 25 2006 6101 6112
53. S.D. Selcuklu, M.T. Donoghue, and C. Spillane miR-21 as a key regulator of oncogenic processes Biochem Soc Trans 37 2009 918 925
54. R.T. Marquez, E. Wendlandt, C.S. Galle, K. Keck, and A.P. McCaffrey MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling Am J Physiol Gastrointest Liver Physiol 298 2010 G535 G541
55. S. Zhu, M.L. Si, H. Wu, and Y.Y. Mo MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1) J Biol Chem 282 2007 14328 14336
56. F. Meng, R. Henson, and M. Lang Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines Gastroenterology 130 2006 2113 2129
57. L. Rossi, E. Bonmassar, and I. Faraoni Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro Pharmacol Res 56 2007 248 253
58. D.M. Moran, M.A. Mattocks, P.A. Cahill, L.G. Koniaris, and I.H. McKillop Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway J Surg Res 147 2008 23 33
59. M. Soresi, L. Giannitrapani, and F. D'Antona Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma World J Gastroenterol 12 2006 2563 2568
60. D. Loffler, K. Brocke-Heidrich, and G. Pfeifer Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer Blood 110 2007 1330 1333
61. E. Tili, J.J. Michaille, and A. Cimino Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock J Immunol 179 2007 5082 5089
62. R.M. O'Connell, K.D. Taganov, M.P. Boldin, G. Cheng, and D. Baltimore MicroRNA-155 is induced during the macrophage inflammatory response Proc Natl Acad Sci U S A 104 2007 1604 1609
63. T.H. Thai, D.P. Calado, and S. Casola Regulation of the germinal center response by microRNA-155 Science 316 2007 604 608
64. I. Faraoni, F.R. Antonetti, J. Cardone, and E. Bonmassar miR-155 gene: a typical multifunctional microRNA Biochim Biophys Acta 1792 2009 497 505
65. B. Wang, S. Majumder, and G. Nuovo Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice Hepatology 50 2009 1152 1161
66. A. Budhu, Z. Yu, M. Forgues, Z.Y. Tang, C. Croce, and X.W. Wang Immune cell-related MICRORNA-155 is associated with human liver cirrhosis and hepatocellular carcinoma ILCA Annual Conference (abstract) Sept 4-6, 2009 Milan, Italy
67. E. Bugianesi, N. Leone, and E. Vanni Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
68. T.R. Morgan, S. Mandayam, and M.M. Jamal Alcohol and hepatocellular carcinoma Gastroenterology 127 2004 S87 S96
69. A. Dolganiuc, J. Petrasek, and K. Kodys MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice Alcohol Clin Exp Res 33 2009 1704 1710
70. A. Wasley, and M.J. Alter Epidemiology of hepatitis C: geographic differences and temporal trends Semin Liver Dis 20 2000 1 16
71. Y. Murakami, H.H. Aly, A. Tajima, I. Inoue, and K. Shimotohno Regulation of the hepatitis C virus genome replication by miR-199a J Hepatol 50 2009 453 460
72. S. Kim, U.J. Lee, and M.N. Kim MicroRNA miR-199a (*) regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2) J Biol Chem 283 2008 18158 18166
73. P. Kaposi-Novak, J.S. Lee, L. Gomez-Quiroz, C. Coulouarn, V.M. Factor, and S.S. Thorgeirsson Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype J Clin Invest 116 2006 1582 1595
74. F. Fornari, M. Milazzo, and P. Chieco MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells Cancer Res 70 2010 5184 5193
75. Y. Xiong, J.H. Fang, and J.P. Yun Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma Hepatology 51 2010 836 845
76. J. Massague A very private TGF-beta receptor embrace Mol Cell 29 2008 149 150
77. B. Wang, S.H. Hsu, and S. Majumder TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3 Oncogene 29 2010 1787 1797
78. S. Huang, X. He, and J. Ding Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells Int J Cancer 123 2008 972 978
79. S. Li, H. Fu, and Y. Wang MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma Hepatology 49 2009 1194 1202
80. H. Su, J.R. Yang, and T. Xu MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity Cancer Res 69 2009 1135 1142
81. J. Ji, L. Zhao, and A. Budhu Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma J Hepatol 52 2010 690 697
82. F.F. Lan, H. Wang, and Y.C. Chen Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by down-regulation of c-Myc and up-regulation of p16(INK4A) Int J Cancer 128 2011 319 331
83. S. Shimizu, T. Takehara, and H. Hikita The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma J Hepatol 52 2010 698 704
84. R.E. Lanford, E.S. Hildebrandt-Eriksen, and A. Petri Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 327 2010 198 201
85. W. Li, L. Xie, and X. He Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma Int J Cancer 123 2008 1616 1622
86. Y. Wang, A.T. Lee, and J.Z. Ma Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target J Biol Chem 283 2008 13205 13215
87. E. Connolly, M. Melegari, and P. Landgraf Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype Am J Pathol 173 2008 856 864